Sareum Holdings
SAR · AIM · Health Care · mcap £43m · 27.5p
Financials · LTM to 31 Dec 25
Source: results 12 Mar 26 ↗
- Revenue
- –
- Operating profit
- −£3.9m
- Net income
- −£4.9m
- Free cash flow
- −£3.3m
- Net cash
- £2.5m
- Market cap
- £38.4m
- EV / EBIT
- –
- FCF yield
- −8.7%
- Price / book
- 32.2×
Latest half-year · H1 Dec 25 vs H1 Dec 24
results 12 Mar 26 ↗
- Operating profit
- −£1.8m prior −£1.3m
- Net income
- −£1.7m prior −£1.2m
- Cash from operations
- −£1.5m prior −£756k
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Latest report: H1 Dec 25 (six months to 31 Dec 25), published 12 Mar 26 · read the results ↗
£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source
| Latest Dec 25 | FY Jun 25 | FY Jun 24 | |
|---|---|---|---|
| Associates & JVs | 0.0 | 0.0 | 0.0 |
| Trade receivables | 0.7 | 0.7 | 1.3 |
| Cash | 2.5 | 3.5 | 1.5 |
| Current assets | 3.2 | 4.2 | 2.8 |
| Trade payables | 0.4 | 0.4 | 0.7 |
| Current liabilities | 2.0 | 2.0 | – |
| Total equity | 1.2 | 2.3 | 2.1 |
Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.
Company filings. Not investment advice.